The changing landscape of stage IV lung squamous cell carcinoma: Long-term trends with immune checkpoint inhibitors and contemporary regimens

International Journal of Lung Cancer · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles